Daily brief   for adults 50+ Subscribe AM & PM email
50 Plus HubEverything for Everyone 50+
Customize My age is in the: 50s 60s 70s 80+ Text size Language
‹ Back to Breaking News
health50+

NHS in England to Provide Fampridine for MS Patients

Thursday, July 23, 2026 · 1 sources

The NHS in England will provide the drug Fampridine to eligible multiple sclerosis patients. Up to 5,000 patients may benefit from the treatment.

The NHS in England has announced that it will provide the drug Fampridine to patients with multiple sclerosis. This decision is expected to benefit up to 5,000 patients. Fampridine works by boosting nerve signals, making it easier for patients to walk.

According to reports, the drug has been described as 'life-changing' for some patients. The NHS decision to provide Fampridine is a significant development for multiple sclerosis patients in England.

The treatment is designed to improve mobility in patients with multiple sclerosis, a condition that affects the brain and spinal cord. By enhancing nerve signals, Fampridine can help patients walk more easily, potentially improving their overall quality of life.

The 50+ takeaway: New treatment option for multiple sclerosis patients

Go Deeper

What is Fampridine?

Fampridine is a drug that boosts nerve signals to make it easier for multiple sclerosis patients to walk.

How many patients are eligible for the treatment?

Up to 5,000 multiple sclerosis patients in England are eligible for the Fampridine treatment.

How does Fampridine work?

Fampridine works by enhancing nerve signals, making it easier for patients to walk and potentially improving their mobility.

What condition does Fampridine treat?

Fampridine is designed to treat multiple sclerosis, a condition that affects the brain and spinal cord.

What is the potential impact of Fampridine on patients?

The drug has been described as 'life-changing' for some patients, potentially improving their overall quality of life by enhancing their mobility.